Latest Bids From Kazakh

Sanef/Sapn Construction, Maintenance and Repair of Restraint Devices (Metal or Concrete) Following Accidents 2025-2029

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Erythropoietin (B03xa01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Olanzapine (N05ah03), Without Solid Oral Dosage Forms as Part of a So-Called...

Tender for Home Charging Infrastructure & Charging Cards for Electric Passenger Cars

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Sultiam (N03ax03), only Film-Coated Tablets as Part of a So-Called Open House Model.

Notice of Preliminary Market Consultation Preparatory to the Launch of a Tender Procedure Aimed at the Three-Year In-Service Supply of an Automatic Routine System for Cytotoxic Samples...

It Services for the Maintenance, Evolution and Support of the Madrid City Council's Artificial Intelligence Software Platform.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Nadroparin, Atc B01ab06 (Obg) for the Period November 1St, 2024 - October 31St, 2026

Health Insurance (Centralized Procurement)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Interferon Beta-1A (Exclusively for Subcutaneous Use), Atc L03ab07 for the Period November 1St, 2024 - October 31St, 2026